Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

Boehringer Ingelheim acquires Tyrolean biotech company ViraTherapeutics

© Boehringer Ingelheim

Thanks to yet another large investment, Boehringer Ingelheim is strengthening Austria’s position as a research location and has acquired a 100% stake in the Tyrolean biotech company ViraTherapeutics for EUR 210 million.

The startup which was spun off from the University of Innsbruck in 2013 focuses on the development of oncolytic viral therapies serving as an immunotherapy in the fight against cancer. "The acquisition strengthens Boehringer Ingelheim's commitment to research and development of viral-based immuno-oncology treatment options for cancer patients", says Boehringer Ingelheim.

The company has already been involved with ViraTherapeutics since 2016 together with EMBL Ventures. ViraTherapeutics will become a separate unit of Boehringer Ingelheim's research organization. 19 researchers are currently employed at the facility in Innsbruck. Up until now the shares in ViraTherapeutics were held by Boehringer Ingelheim Venture Fonds, which acquires stakes in innovative startups in the pharmaceutical sector. 22 young companies are currently in the Boehringer Ingelheim portfolio. Boehringer Ingelheim is very strongly committed to both research and production in Austria. The entire cancer research of the company is bundled in Vienna. At present the Group is investing about EUR 700 million in a new biotech production plant in Vienna.

Read more:

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Doing Business in Austria

    03.03.2020, Bratislava, Slovakia

  • Austria as a European window for Russian export opportunities

    05.03.2020, Moscow, Russia

Austria Map

Find the perfect location for your company
Vienna’s unique location at the heart of Europe makes it an important centre and very popular with the global pharmaceutical and biotechnology industry. Vienna is where Eastern Europe meets Western Europe. Businesses located at this international hub benefit from well-established infrastructures and highly-qualified professionals. The significant growth in the Life Sciences sector in Vienna over the last few years is an indicator of the momentum in the industry.

ABF Pharmaceutical Services

ABF Pharmaceutical Services
More testimonials

news from the business location Austria

Many-body quantum physics

Many of the biggest questions in physics can be answered with the help of quantum field theories: They are needed to describe the dynamics of many interacting particles. These theories are just as essential in solid state physics as they are in cosmology.

Growing demand for natural active ingredients enables Phytovalley Tyrol to flourish

The comeback of plant-based active ingredients in medicine, cosmetics and food production has positive impacts on Tyrol as a business location. Austria has succeeded in playing a pioneering role in plant research thanks to the support of the federal government, the Federal Province of Tyrol, the company Bionorica and the University of Innsbruck. This niche in plant research already established itself in Innsbruck years ago.

More news All blog posts